2Chambers G, Lawrie L, Cash P.Proteomics: a new approach to the study of disease. J Pathol, 2000;192:280-288
3Banks RE, Dunn M J, Hochstrasser DF, et al. Proteomics: new perspectives , new biomedical opportunities. Lancet. 2000;356:1749-1756
4Pandey A, Mann M. Proteomics to study genes and genomes. Nature, 2000; 405:837-846
5Yokoo H, Kondo T, Fujii K, et al. Proteomic signature corresponding to alpha fetoprotein expression in liver cancer cells [J]. Hepatology,2004;40(3): 609-617
6Keith CT, Bo risy AA, Stockwell BR.M uhicomponent therapeutics for netwo rked systems[J].Nat Rev Drug Discov, 2005;4(1):71-78
7Fitzgerald JB, Schoeberl B, Nielsen UB, et al.System sbiotogy and combination therapy in the quest for clinical efficacy [J].Nat Chem Biol, 2006;2(9): 458-466
